106.81 USD
+1.16 (+1.1%)
Last: Jan 30, 2026, 04:30 PM
No Fundamental Analysis report for PPH not available.
VANECK PHARMACEUTICAL ETF / PPH FAQ
What is the ChartMill fundamental rating of VANECK PHARMACEUTICAL ETF (PPH) stock?
ChartMill assigns a fundamental rating of null / 10 to PPH.
Can you provide the valuation status for VANECK PHARMACEUTICAL ETF?
ChartMill assigns a valuation rating of null / 10 to VANECK PHARMACEUTICAL ETF (PPH). This can be considered as Overvalued.
What is the profitability of PPH stock?
VANECK PHARMACEUTICAL ETF (PPH) has a profitability rating of null / 10.